Yahoo Web Search

  1. Merck's Keytruda fails as monotherapy in breast cancer study

    Reuters via Yahoo FinanceMay 20 20:59 PM

    Merck & Co Inc said on Monday its blockbuster cancer drug Keytruda failed to meet the main goal of a late-stage study testing the treatment as a monotherapy in patients ...

  2. AbbVie's Brain Cancer Candidate Fails in Phase III Study

    Zacks via Yahoo FinanceMay 20 13:02 PM

    AbbVie, Inc. ABBV announced that a late-stage study evaluating its pipeline candidate, depatuxizumab mafodotin (Depatux-M) failed to show any survival benefit in patients with newly diagnosed ...

  3. Why Merck (MRK) is a Great Dividend Stock Right Now

    Zacks via Yahoo FinanceMay 20 13:15 PM

    A dividend is that coveted distribution of a company's earnings paid out to shareholders, and investors often view it by its dividend yield, a metric that measures the dividend as a percent of the current stock price.

  4. Bristol-Myers Squibb Co (NYSE: BMY)'s quest to expand its oncology franchise through its proposed acquisition of Celgene Corporation (NASDAQ: CELG) may not be a wise move, according to ...

  5. Canada Pension Plan Investment Board said it had paid about $1.3 billion for a part of British charity LifeArc's royalty interest from the sale of Merck & Co Inc's blockbuster ...

  1. Ads
    related to MERCK & CO., INC